These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33767408)
1. Potential value of lncRNAs as a biomarker for proliferative diabetic retinopathy. Liu B; Cong C; Ma Y; Ma X; Zhang H; Wang J Eye (Lond); 2022 Mar; 36(3):575-584. PubMed ID: 33767408 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285 [TBL] [Abstract][Full Text] [Related]
3. Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in Proliferative Diabetic Retinopathy Patients. Wang J; Gao X; Liu J; Wang J; Zhang Y; Zhang T; Zhang H Acta Ophthalmol; 2019 Sep; 97(6):e902-e912. PubMed ID: 30900812 [TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood. Wu Z; Liu B; Ma Y; Chen H; Wu J; Wang J Acta Ophthalmol; 2021 May; 99(3):306-313. PubMed ID: 32914551 [TBL] [Abstract][Full Text] [Related]
5. High level of lncRNA NR2F1-AS1 predict the onset and progression of diabetic retinopathy in type 2 diabetes. Ji X; Sun J; Wang Z Exp Eye Res; 2022 Jun; 219():109069. PubMed ID: 35398206 [TBL] [Abstract][Full Text] [Related]
6. Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Qing S; Yuan S; Yun C; Hui H; Mao P; Wen F; Ding Y; Liu Q Cell Physiol Biochem; 2014; 34(5):1733-40. PubMed ID: 25427542 [TBL] [Abstract][Full Text] [Related]
7. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980 [TBL] [Abstract][Full Text] [Related]
8. Identification and comprehensive analysis of ferroptosis-related genes as potential biomarkers for the diagnosis and treatment of proliferative diabetic retinopathy by bioinformatics methods. Cao D; Wang C; Zhou L Exp Eye Res; 2023 Jul; 232():109513. PubMed ID: 37207868 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy. Shao J; Zhang Y; Fan G; Xin Y; Yao Y BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521 [TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191 [TBL] [Abstract][Full Text] [Related]
11. Expressions of Serum lncRNAs in Diabetic Retinopathy - A Potential Diagnostic Tool. Biswas S; Coyle A; Chen S; Gostimir M; Gonder J; Chakrabarti S Front Endocrinol (Lausanne); 2022; 13():851967. PubMed ID: 35464068 [TBL] [Abstract][Full Text] [Related]
12. Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy. Wang Y; Fang J; Niu T; Xing X; Wang H; Shi X; Liu Y; Liu X; Chen C; Liu K Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):49-55. PubMed ID: 35838805 [TBL] [Abstract][Full Text] [Related]
13. Association between lncRNAs in plasma exosomes and diabetic retinopathy. Ye Q; Li L; Shao Z; Xu M; Li L; Yan Q; Huang B; Zhao T Front Endocrinol (Lausanne); 2022; 13():987488. PubMed ID: 36187126 [TBL] [Abstract][Full Text] [Related]
14. Serum cortisol is a biomolecular biomarker for severity of diabetic retinopathy. Mohan A; Saxena S; Kaur A; Ali W; Akduman L Mol Vis; 2021; 27():429-437. PubMed ID: 34267498 [TBL] [Abstract][Full Text] [Related]
15. Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy. Wang N; Ding L; Liu D; Zhang Q; Zheng G; Xia X; Xiong S Front Endocrinol (Lausanne); 2022; 13():918605. PubMed ID: 35957838 [TBL] [Abstract][Full Text] [Related]
16. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy. Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029 [TBL] [Abstract][Full Text] [Related]
17. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians. Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823 [No Abstract] [Full Text] [Related]
18. MicroRNA-425-5p Is Involved in the Development of Diabetic Retinopathy and Regulates the Proliferation and Migration of Retinal Microvascular Endothelial Cells. Liu X; Zhou Y; Liu Y; Wang Q; Pan L Ophthalmic Res; 2022; 65(1):60-67. PubMed ID: 34571504 [TBL] [Abstract][Full Text] [Related]
19. Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and Huang J; Zhou Q Front Immunol; 2022; 13():858972. PubMed ID: 35651615 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis. Yang QH; Zhang Y; Zhang XM; Li XR Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]